Antibe Therapeutics Inc. (“Antibe”) (TSXV:ATE, OTCQX:ATBPF) filed its financial and operating results today for the fiscal quarter ended December 31, 2014. The Corporation’s unaudited Q3...
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE; OTCQX: ATBPF) is pleased to report results from animal proof-of-concept studies on ATB-352, which is the second drug in...
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE; OTCQX:ATBPF) is pleased to report that the pre-scheduled single ascending dose portion of its Phase I program has been...
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE; OTCQX:ATBPF) is pleased to report the results of the voting on the matters submitted to the annual meeting of shareholders...
OTC Markets Group Welcomes Antibe Therapeutics to OTCQX® PR Newswire NEW YORK, Sept. 15, 2014 NEW YORK, Sept. 15, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0.2156 | 0.2156 | 0.2156 | 0 | 0 | CS |
52 | -0.5454 | -71.6688567674 | 0.761 | 0.7904 | 0.1113 | 31959 | 0.39198279 | CS |
156 | -0.29067 | -57.4140280878 | 0.50627 | 0.8855 | 0.1113 | 12888 | 0.46465047 | CS |
260 | -0.1782 | -45.251396648 | 0.3938 | 5.88 | 0.1113 | 79541 | 0.6613346 | CS |
Symbole | Prix | Vol. |
---|---|---|
GRLFGreen Leaf Innovations Inc (PK) | US$ 0,0002 (100,00%) | 228,93M |
GMPRGourmet Provisions International Corporation (PK) | US$ 0,000001 (-99,00%) | 164,82M |
HMBLHUMBL Inc (PK) | US$ 0,0007 (16,67%) | 154,01M |
THBDThird Bench Inc (PK) | US$ 0,0001 (-33,33%) | 133,1M |
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,0028 (-6,67%) | 110,11M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales